New Updates in Drug Formulation & Bioavailability

The pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems. However, many of the drugs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require the use of new and enabling formulation approaches.

Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic at this meeting featuring about 100 delegates and 10 exhibitors. 

New updates in Drug Formulation & Bioavailability is a platform based on the concept of synergies between “science” and “business”. The presented content and topics will focus on advancements in formulations and cutting edge technologies that can allow cheaper, safer and effective drugs.

Date: April 3rd, 2019
Time: 8:30  – 17:00 
Venue: Edvard Thomsens Vej 14, Ørestaden, DK-2300 København S

READ MORE & SIGN UP

Among the speakers:

	Moderator Korbinian Löbmann Associate Professor Department of Pharmacy, University of Copenhagen
	Dr Finn Bauer Head of Solid Formulations R&D, Merck Solubility Enhancement through Silica Carrier Materials – Graduating from Lab Scale to Manufacturing
	Henrik Palmelund PhD Fellow, MSc Pharm University of Copenhagen Deep eutectic solvents: a potential tailor-made excipients approach for poorly soluble drugs?
	Jorrit Jeroen Water Principal Scientist, Oral Formulation Research, Novo Nordisk A/S Oral delivery of peptides and proteins
	Jukka Rantanen Professor, Manufacturing and Materials Research Group, University of Copenhagen Innovative manufacturing of personalized medicine
	Sami Svanbäck The Solubility Company, Helsinki Redefining Solubility Analysis – Image-based Measurement Using the SPA Method
	Anders Broo PhD, Senior Principal Scientist, IMED Biotech Unit, AstraZeneca Gothenburg Predictive modeling and AI/ML in discovery and development at AstraZeneca

The target audience consists of:
Drug formulation professionals from Big Pharma, CDMO’s, Academia
Early Phase & virtual biotech and pharma companies
QA & Reg Aff. Managers
Procurement Managers
Speakers will come from:
Pharmaceutical companies, Excipient manufacturers, CDMO’s, Academia

Topics will include:
– Formulation development design space
– Improving bioavailability of poorly soluble compounds
– Controlled and modified release technologies
– Out-sourcing and in-licensing
– Exploring different routes of administration in enhancing macromolecule delivery